Lincoln Capital LLC Becton Dickinson & CO Transaction History

Lincoln Capital LLC

  • $461 Million
  • Q3 2024

A detailed history of Lincoln Capital LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Lincoln Capital LLC holds 15,037 shares of BDX stock, worth $3.43 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
15,037
Previous 15,674 4.06%
Holding current value
$3.43 Million
Previous $3.66 Million 1.04%
% of portfolio
0.79%
Previous 0.84%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
SELL
$221.47 - $242.41 $141,076 - $154,415
-637 Reduced 4.06%
15,037 $3.63 Million
Q2 2024

Jul 22, 2024
SELL
$225.07 - $246.17 $31,959 - $34,956
-142 Reduced 0.9%
15,674 $3.66 Million
Q1 2024

Apr 15, 2024
SELL
$233.45 - $247.73 $80,540 - $85,466
-345 Reduced 2.13%
15,816 $3.91 Million
Q4 2023

Jan 10, 2024
SELL
$232.24 - $267.23 $41,803 - $48,101
-180 Reduced 1.1%
16,161 $3.94 Million
Q3 2023

Oct 10, 2023
SELL
$254.9 - $283.59 $210,802 - $234,528
-827 Reduced 4.82%
16,341 $4.22 Million
Q2 2023

Aug 04, 2023
SELL
$238.39 - $265.32 $39,334 - $43,777
-165 Reduced 0.95%
17,168 $4.53 Million
Q1 2023

Apr 26, 2023
SELL
$229.71 - $259.35 $53,752 - $60,687
-234 Reduced 1.33%
17,333 $4.29 Million
Q4 2022

Jan 18, 2023
SELL
$218.29 - $256.91 $139,050 - $163,651
-637 Reduced 3.5%
17,567 $0
Q3 2022

Oct 26, 2022
BUY
$51.03 - $264.23 $20,820 - $107,805
408 Added 2.29%
18,204 $4.06 Million
Q2 2022

Jul 20, 2022
SELL
$234.74 - $275.42 $234 - $275
-1 Reduced 0.01%
17,796 $4.39 Million
Q1 2022

May 05, 2022
SELL
$243.64 - $270.48 $51,895 - $57,612
-213 Reduced 1.18%
17,797 $4.73 Million
Q4 2021

Jan 18, 2022
SELL
$230.08 - $250.94 $14,034 - $15,307
-61 Reduced 0.34%
18,010 $4.53 Million
Q3 2021

Oct 13, 2021
SELL
$232.72 - $256.47 $39,562 - $43,599
-170 Reduced 0.93%
18,071 $4.44 Million
Q2 2021

Jul 14, 2021
SELL
$232.65 - $254.58 $34,897 - $38,187
-150 Reduced 0.82%
18,241 $4.44 Million
Q1 2021

May 13, 2021
SELL
$232.09 - $256.88 $9,747 - $10,788
-42 Reduced 0.23%
18,391 $4.47 Million
Q4 2020

Jan 19, 2021
SELL
$221.92 - $245.94 $35,285 - $39,104
-159 Reduced 0.86%
18,433 $4.61 Million
Q3 2020

Oct 13, 2020
SELL
$215.77 - $276.76 $42,290 - $54,244
-196 Reduced 1.04%
18,592 $4.33 Million
Q2 2020

Jul 15, 2020
SELL
$219.9 - $263.41 $8,796 - $10,536
-40 Reduced 0.21%
18,788 $4.5 Million
Q1 2020

Apr 16, 2020
SELL
$195.69 - $279.01 $18,394 - $26,226
-94 Reduced 0.5%
18,828 $4.33 Million
Q4 2019

Jan 21, 2020
SELL
$236.45 - $266.82 $3,310 - $3,735
-14 Reduced 0.07%
18,922 $5.15 Million
Q3 2019

Oct 22, 2019
SELL
$230.58 - $256.08 $84,161 - $93,469
-365 Reduced 1.89%
18,936 $4.79 Million
Q2 2019

Jul 16, 2019
BUY
$217.4 - $246.08 $2,826 - $3,199
13 Added 0.07%
19,301 $4.86 Million
Q1 2019

Apr 16, 2019
SELL
$206.05 - $248.17 $17,720 - $21,342
-86 Reduced 0.44%
19,288 $4.82 Million
Q4 2018

Feb 15, 2019
BUY
$204.73 - $257.93 $29,685 - $37,399
145 Added 0.75%
19,374 $4.37 Million
Q3 2018

Nov 14, 2018
SELL
$233.07 - $256.0 $17,713 - $19,456
-76 Reduced 0.39%
19,229 $5.02 Million
Q2 2018

Jul 13, 2018
SELL
$208.1 - $233.85 $8,324 - $9,354
-40 Reduced 0.21%
19,305 $4.72 Million
Q1 2018

Apr 16, 2018
BUY
$205.46 - $240.27 $96,977 - $113,407
472 Added 2.5%
19,345 $4.19 Million
Q4 2017

Jan 17, 2018
SELL
$189.0 - $222.64 $189 - $222
-1 Reduced 0.01%
18,873 $4.04 Million
Q3 2017

Oct 19, 2017
BUY
$186.89 - $198.9 $3.53 Million - $3.75 Million
18,874
18,874 $3.7 Million

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Lincoln Capital LLC Portfolio

Follow Lincoln Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email